FDA Schedules Public Meeting on Premarket Clearance Process for Medical
FDA Schedules Public Meeting on Premarket Clearance Process for Medical Devices
The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.